Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response

Simon Ghaly, S. Costello, L. Beswick, A. Pudipeddi, A. Agarwal, A. Sechi, S. Antoniades, B. Headon, S. Connor, Ian Lawrance, M. Sparrow, A. Walsh, J. Andrews

    Research output: Contribution to journalArticlepeer-review

    4 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response'. Together they form a unique fingerprint.

    Medicine & Life Sciences